The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A call for global harmonization of phase I oncology trials: Results from two parallel, first-in-human phase I studies of DS-7423, an oral PI3K/mTOR dual inhibitor in advanced solid tumors conducted in the United States and Japan.
 
Tomoya Yokota
Honoraria - AstraZeneca; Eisai; Merck Serono; Nihonkayaku; Niphix; Ono Pharmaceutical; Otsuka; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Merck Serono
Research Funding - AstraZeneca (Inst); MSD (Inst); NanoCarrier (Inst); Novartis (Inst); Pfizer (Inst)
 
Johanna C. Bendell
Research Funding - Abbott/AbbVie (Inst); Agios (Inst); Apexigen (Inst); ARMO BioSciences (Inst); Array BioPharma (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Celldex (Inst); CytomX Therapeutics (Inst); Daiichi Sankyo (Inst); Eisai (Inst); EMD Serono (Inst); Five Prime Therapeutics (Inst); Forty Seven (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Kolltan Pharmaceuticals (Inst); Leap Therapeutics (Inst); Lilly (Inst); Macrogenics (Inst); Merck (Inst); Novartis (Inst); Oncogenex (Inst); OncoMed (Inst); Onyx (Inst); Sanofi (Inst); Stem CentRx (Inst); SynDevRx (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); TG Therapeutics (Inst)
 
Patricia LoRusso
Leadership - Alexion Pharmaceuticals; Boehringer Ingelheim; Genentech/Roche; Novartis
Honoraria - Genentech/Roche
Consulting or Advisory Role - Alexion Pharmaceuticals; Astellas Pharma; Astex Pharmaceuticals; Boehringer Ingelheim; Genentech; Novartis; Pfizer
Speakers' Bureau - Genentech
Research Funding - Alexion Pharmaceuticals; Boehringer Ingelheim; Genentech (Inst); Immunogen (Inst); Merrimack (Inst); Novartis (Inst); Pfizer; Taiho Pharmaceutical (Inst); Tensha Therapeutics (Inst)
Travel, Accommodations, Expenses - Alexion Pharmaceuticals; Genentech/Roche
 
Takahiro Tsushima
Honoraria - Chugai Pharma; Taiho Pharmaceutical; Takeda
 
Ved Desai
No Relationships to Disclose
 
Hirotsugu Kenmotsu
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb Japan; Chugai Pharma; Kyowa Hakko Kirin; Lilly; Ono Pharmaceutical; Taiho Pharmaceutical
Research Funding - AstraZeneca/MedImmune (Inst); Boehringer Ingelheim (Inst); Chugai Pharma (Inst)
 
Junichiro Watanabe
Honoraria - AstraZeneca Japan; Chugai Pharma; Eisai; Kyowa Hakko Kirin; Novartis; Taiho Pharmaceutical
Consulting or Advisory Role - AstraZeneca Japan; Eisai
 
Akira Ono
Honoraria - Chugai Pharma; Taiho Pharmaceutical
Research Funding - Takeda (Inst)
 
Bhavani G. Murugesan
No Relationships to Disclose
 
Joseph Silva
No Relationships to Disclose
 
Tateaki Naito
Honoraria - Ono Pharmaceutical
 
Jonathan Greenberg
Employment - Daiichi Sankyo
Stock and Other Ownership Interests - Daiichi Sankyo
Travel, Accommodations, Expenses - Daiichi Sankyo
 
Prasanna Kumar
Employment - Daiichi Sankyo
Stock and Other Ownership Interests - Daiichi Sankyo
 
Yibin Wang
Employment - Daiichi Sankyo
Stock and Other Ownership Interests - Daiichi Sankyo
 
Takahiro Jikoh
Employment - Daiichi Sankyo
 
Ryota Shiga
Employment - Daiichi Sankyo
 
Alan Loh Ho
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; Genzyme; Merck; Novartis; Novartis; oncology consortium; Sun Pharma
Speakers' Bureau - Medscape; Omniprex America
Research Funding - AstraZeneca; AstraZeneca; Bayer; Eisai; Genentech/Roche; Kolltan Pharmaceuticals; Kura Oncology; Lilly
Travel, Accommodations, Expenses - Janssen Oncology; Merck
 
Mrinal M. Gounder
Honoraria - Amgen; Daiichi Sankyo; Karyopharm Therapeutics; TRACON Pharma
Consulting or Advisory Role - Amgen; Daiichi Sankyo; Epizyme; Karyopharm Therapeutics
Speakers' Bureau - Amgen
Travel, Accommodations, Expenses - Amgen; Daiichi Sankyo; Karyopharm Therapeutics